Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?

Background: This study aims to analyse whether in acute heart failure (AHF) with iron deficiency (ID), the administration of ferric carboxymaltose (FCM) produces a greater benefit in renal dysfunction. Methods: A total of 812 consecutive patients admitted for AHF and ID were studied. Untreated (n:27...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Vilella, Raquel, Guerrero Cervera, Borja, Donoso Trenado, Víctor, Sánchez-Lázaro, Ignacio, Martínez Dolz, Luis, Almenar Bonet, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144873/
https://www.ncbi.nlm.nih.gov/pubmed/37109444
http://dx.doi.org/10.3390/life13040915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144873/
https://www.ncbi.nlm.nih.gov/pubmed/37109444
http://dx.doi.org/10.3390/life13040915

Ejemplares similares